Moderna (MRNA)

Income Tax Expense

$64.00M

TTM · Period ending: · USD

MRNA logo

MRNA Income Tax Expense

Latest reported$64.00M
MRNA TTM Income Tax (-$80.00K → $64.00M)
High-resolution chart · PNG

MRNA income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
64,000,000
56,000,000
54,000,000
-37,000,000
-42,000,000
-49,000,000
-46,000,000
-129,000,000
1,535,000,000
1,166,000,000
772,000,000
1,109,000,000
-389,000,000
257,000,000
1,213,000,000
1,565,000,000
1,610,000,000
1,616,000,000
1,083,000,000
542,473,000
324,337,000
41,485,000
2,551,000
909,000
-133,000
-605,000
-695,000
-358,000
-180,000
302,000
139,000
-200,000
-202,000
-313,500
-80,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.